香港欣诺康医药科技

Xinnuokang Pharmaceutical Technology is a specialized pharmaceutical research and development organization that provides comprehensive CRO and CDMO services to the global life sciences industry. The company focuses on the synthesis of drug impurities, reference standards, and the development of small molecule generics, including consistency evaluation services. With its primary operations in Beijing and an international corporate presence in Hong Kong, Xinnuokang supports pharmaceutical manufacturers through CMC documentation, process optimization, and technology transfer. Their extensive catalog of chemical intermediates and over 2,000 types of drug impurities makes them a key partner for quality control and regulatory compliance in drug manufacturing. The company is dedicated to accelerating the drug commercialization process by providing high-quality analytical and synthetic support.